← Back to Search

Renal Replacement Therapy

hemodiafiltration On-line for Chronic Kidney Disease (PHARMACO-$ Trial)

N/A
Waitlist Available
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

PHARMACO-$ Trial Summary

This trial will compare the two treatment modalities, HD and HDF, through economics and pharmaco-economics parameters.

Eligible Conditions
  • Chronic Kidney Disease
  • Hemodialysis

PHARMACO-$ Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
compare the medication cost between the 2 groups (HD and HDF)
demonstrate lower cost of erythropoietin in HDF, with same control of anemia to HD group
demonstrate lower cost of phosphate binder in HDF, with same control of phospho calcium balance to HD group
Secondary outcome measures
demonstrate less hospitalization stay and cost related in HDF group
demonstrate lower need of Erythropoietin and best control of anemia in HDF
demonstrate lower need of phosphate binder and best control of phospho-calcique balance in HDF
+1 more

PHARMACO-$ Trial Design

2Treatment groups
Active Control
Group I: hemodiafiltration On-lineActive Control1 Intervention
hemodiafiltration On-line
Group II: conventional hemodialysisActive Control1 Intervention
conventional hemodialysis

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,497 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently able to enroll in this exploration?

"As per clinicaltrials.gov, this trial is no longer seeking patients; it was first posted on January 1st 2011 and last updated on August 10th 2021. Despite being inactive, there are still 204 trials actively recruiting participants at the moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit
2011. "Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02374372.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top